In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban.

In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban.

Journal of thrombosis and haemostasis : JTH (2007-03-29)

G T Gerotziafas, I Elalamy, F Depasse, E Perzborn, M M Samama

MATERIALS

Product Number

Brand

Product Description

Sigma-Aldrich

Rivaroxaban, ≥98% (HPLC)